NEWMARK GROUP, INC. (NMRK) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 3.06B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | |
| Operating income | 276.15M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $3.06B | (m) | $276.15M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $2.93B | (m) | $278.48M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $2.77B | (m) | $234.00M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $2.64B | (m) | $214.27M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $2.49B | (m) | $170.16M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $2.38B | (m) | $168.13M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $2.27B | (m) | $163.04M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $2.19B | (m) | $138.59M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $2.14B | (m) | $127.59M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $2.09B | (m) | $114.42M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $2.08B | (m) | $125.22M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $1.95B | (m) | $71.13M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $1.99B | (m) | $99.57M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $2.17B | (m) | $161.17M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $2.30B | (m) | $185.57M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $2.65B | (m) | $389.15M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $2.77B | (m) | $556.23M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $2.67B | (m) | $1.20B | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $2.50B | (m) | $1.25B | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $2.10B | (m) | $1.03B | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $1.73B | (m) | $945.21M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $1.46B | (m) | $219.90M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $1.44B | (m) | $184.00M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $1.52B | (m) | $172.86M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $1.68B | (m) | $198.03M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $1.86B | (m) | $236.51M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $1.84B | (m) | $246.24M | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $1.82B | (m) | $345.68M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $1.78B | (m) | $341.12M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $1.72B | (m) | $317.55M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $1.70B | (m) | $332.59M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $1.60B | (m) | $199.79M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $1.35B | (m) | $167.42M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.